Home/Filings/4/0001209191-23-010638
4//SEC Filing

LaFrance Norman D. 4

Accession 0001209191-23-010638

CIK 0001095981other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:30 PM ET

Size

5.6 KB

Accession

0001209191-23-010638

Insider Transaction Report

Form 4
Period: 2023-02-15
LaFrance Norman D.
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-15+74,98174,981 total
    Exercise: $0.39Exp: 2033-02-15Common Stock (74,981 underlying)
Footnotes (1)
  • [F1]The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001397768

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:30 PM ET
Size
5.6 KB